Cytokines and chemokines as predictive markers in non-small cell lung cancer patients with brain metastases.
Altundag
Ozden
O
Altundag
Kadri
K
Morandi
Paolo
P
Gunduz
Mehmet
M
D014408:Biomarkers, Tumor / Q000032:analysis*; D001932:Brain Neoplasms / Q000276:immunology* / Q000556:secondary*; D002289:Carcinoma, Non-Small-Cell Lung / Q000276:immunology* / Q000556:secondary*; D054377:Chemokine CXCL12; D019743:Chemokines, CXC / Q000032:analysis / Q000276:immunology*; D006801:Humans; D053661:Interleukin-13 Receptor alpha1 Subunit; D008175:Lung Neoplasms / Q000276:immunology* / Q000473:pathology*; D009367:Neoplasm Staging; D011237:Predictive Value of Tests; D011379:Prognosis; D018123:Receptors, Interleukin / Q000032:analysis / Q000276:immunology*; D053660:Receptors, Interleukin-13
D014408:Biomarkers, Tumor; C515255:CXCL12 protein, human; D054377:Chemokine CXCL12; D019743:Chemokines, CXC; C508181:IL13RA1 protein, human; D053661:Interleukin-13 Receptor alpha1 Subunit; D018123:Receptors, Interleukin; D053660:Receptors, Interleukin-13